Predictors of prolonged treatment time intervals in oral cavity cancer
- PMID: 37948896
- DOI: 10.1016/j.oraloncology.2023.106622
Predictors of prolonged treatment time intervals in oral cavity cancer
Abstract
Objectives: Delays in treatment time intervals have been associated with overall survival in oral cavity squamous cell carcinoma (OCSCC). The aim of this study was to identify bottlenecks leading to prolonged treatment intervals.
Material and methods: A retrospective analysis was conducted using a cohort of OCSCC patients who underwent surgery and adjuvant radiation therapy. The endpoints of interest were prolonged treatment intervals. Multivariable logistic regression was used to adjust for patient and tumour characteristics.
Results: Median diagnosis-to-treatment interval (DTI) and surgery to initiation of postoperative radiation therapy interval (S-PORT) were 39 days (IQR 30-54) and 64 days (IQR 54-66), respectively. Prolonged DTI was associated with older age, worse Charlson Comorbidity index scores and worse T stages. Patients with prolonged DTI had longer times to preoperative imaging reports (25 vs 9 days; P < 0.01). Time to preoperative pathology did not differ. Prolonged S-PORT was associated with longer times to pathology report (28 vs 18 days; P < 0.01), to maxillofacial consult (38 vs 15 days; P < 0.01) and to maxillofacial approval of radiation (50 vs 28 days; P < 0.01). In patients requiring medical oncology consults, those with prolonged S-PORT had longer waiting times until consultation (58 vs 38 days; P = 0.02). Multivariate analysis showed independent predictors of prolonged DTI: time to preoperative imaging; and prolonged S-PORT: time to pathology report, time to maxillofacial consult, and time to medical oncology consult.
Conclusions: Strategies targeting these organizational bottlenecks may be effective for shortening treatment time intervals, hence representing potential opportunities for improving oncological outcomes in OCSCC patients.
Keywords: Diagnosis to treatment interval; Guideline adherence; Hospital administration; Multidisciplinary care; Patient trajectory; Post-operative radiation therapy; Radiation therapy interval; Surgery to postoperative radiation therapy interval; Time management; Treatment time intervals.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Gabriel Dayan: none declared. Houda Bahig: grants from Varian Medical Systems and personal fees from AstraZeneca outside the submitted work. Bernard Fortin: none declared. Édith Filion: none declared. Phuc-Felix Nguyen Tan: none declared. Brian O’Sullivan: none declared. Danielle Charpentier: none declared. Denis Soulières: none declared. Olga Gologan: none declared. Kristoff Nelson: none declared. Laurent Létourneau: none declared. Matthieu Schmittbuhl: none declared. Tareck Ayad: none declared. Eric Bissada: none declared. Louis Guertin: none declared. Apostolos Christopoulos: personal fees from Sanofi (advisory board) and Merck (presenter) outside the submitted work.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical